Reset Map11 Results
The Old Glassworks Nettlefold Road Cardiff, CF24 5JQ United KingdomPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
No. 800 Bin-Hai 4th Road Hangzhou Bay New Zone Ningbo, 315336 ChinaPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
12 Cabot Road Suite 12 A&T Woburn, Massachusetts, 01801 United StatesPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
Building C, No. 7 Fenglong Road, High-tech Zone Qingdao, Shandong, 266114 ChinaPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
1980, Guangde Road, Airport New City, Xi'an, Shanxi, 712034 ChinaPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
20340 Seneca Meadows Parkway Germantown, MD, 20876 United StatesPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
Pegasus Way Crown Business Park Rushden , Northamptonshire, NN10 6ER United KingdomPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
No 6 Taihe Road, BDA Beijing, 100176 ChinaPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
12 Cabot Road Suite 12 A&T Woburn, MA, 01801 United StatesPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
2820 Loker Ave E Carlsbad, CA, 92010 United StatesPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
201 East Jefferson Street Louisville, KY, 40202 United StatesPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.